SWK002
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SWK002, covering 2025-02-28 to 2025-02-28. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of SWK002 in Patients With D2T-Rheumatoid Arthritis [NA]